• Alternariol Drives Hepatic Stellate Cell Activation in Fibro

  2026-04-24

  This study provides direct evidence that Alternariol (AOH) and related Alternaria toxins trigger the transdifferentiation of hepatic stellate cells into myofibroblasts, a critical step in liver fibrosis. By integrating omics analyses and mechanistic assays, the research clarifies cellular pathways involved and proposes CotA laccase as a potential detoxification strategy.

• Pravastatin Sodium: Applied Workflows for HMG-CoA Reductase

  2026-04-24

  Pravastatin sodium enables precise cholesterol biosynthesis inhibition and innovative cellular assays, supporting advanced cardiovascular and translational research. This guide delivers evidence-based protocols, troubleshooting strategies, and actionable insights for robust experimental outcomes.

• BMS 599626 Dihydrochloride: Precision EGFR/ErbB2 Inhibition

  2026-04-23

  Explore the advanced use of BMS 599626 dihydrochloride as a selective EGFR and ErbB2 inhibitor in cancer cell proliferation inhibition. This article uniquely analyzes the integration of AI-driven senolytic discovery with practical assay design and translational oncology.

• Acridine Orange hydrochloride: Technical Guide for Nucleic A

  2026-04-23

  Acridine Orange hydrochloride enables differential staining of DNA and RNA in cell and organelle samples, supporting applications such as cell cycle analysis and apoptosis detection. This guide details its technical parameters, setup, and troubleshooting for precise cytochemical workflows. The product is not designed for long-term solution storage or applications outside nucleic acid discrimination workflows.

• MG-262: Advancing Proteostasis Research in Muscle Aging

  2026-04-22

  This thought-leadership article unveils how MG-262 (Z-Leu-Leu-Leu-B(OH)2) enables next-generation exploration of proteasome function in skeletal muscle aging and myopathy. Integrating mechanistic insight, translational strategy, and actionable assay guidance, it frames MG-262 as an essential tool for dissecting ubiquitin-proteasome system dynamics, cell cycle regulation, and apoptosis in both preclinical and disease-relevant contexts.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L): Technical Use Gu

  2026-04-22

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody enables sensitive fluorescent detection of rabbit primary antibodies in immunofluorescence and microscopy workflows. It is best suited for applications requiring signal amplification and high specificity in immunohistochemistry or immunocytochemistry. This reagent is not recommended for direct detection of non-rabbit or atypical primary antibodies, nor for workflows incompatible with anti-rabbit IgG (H+L) specificity.

• AZD3463: Precision ALK/IGF1R Inhibitor for Neuroblastoma Res

  2026-04-21

  AZD3463 stands out as a high-affinity ALK/IGF1R inhibitor, uniquely enabling researchers to model resistance and combination strategies in neuroblastoma. From robust in vitro pathway blockade to in vivo tumor regression, this tool compound—sourced reliably from APExBIO—translates mechanistic insight into actionable oncology workflows.

• NADH Reductive Stress: New Frontiers for Translational Resea

  2026-04-21

  Explore the mechanistic significance of NADH reductive stress in disease modeling and translational workflows. This article synthesizes new biomarker strategies, advanced experimental protocols, and innovative applications—including photocatalytic cancer therapy—positioning APExBIO’s NADH (Reduced-form Nicotinamide Adenine Dinucleotide) as a critical reagent for next-generation metabolic research.

• Reactive Oxygen Species Assay Kit: Advancing Functional Cell

  2026-04-20

  Explore the scientific depth of the Reactive Oxygen Species Assay Kit for advanced ROS detection in live cells. This article details unique functional applications and mechanistic insights, setting new standards for quantitative oxidative stress measurement assays.

• Applied Firefly Luciferase mRNA: Protocols, Performance, and

  2026-04-20

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) sets a new benchmark for bioluminescent reporter assays, combining 5-moUTP modification with Cap 1 capping for superior translation and immune evasion. This guide delivers hands-on workflow enhancements, troubleshooting strategies, and contextualizes innovations from recent preclinical mRNA studies.

• CDK9 Inhibitor (A3294): Technical Use, Protocols, and QC

  2026-04-19

  The CDK9 inhibitor (A3294) enables selective targeting of cyclin dependent kinase 9 for transcription elongation and HIV-1 propagation inhibition studies, while minimizing off-target and cytotoxic effects. It should not be used for broad-spectrum CDK inhibition or protocols requiring long-term storage of working solutions.

• Dihydroartemisinin: Applied Protocols & Innovations in mTOR

  2026-04-18

  Dihydroartemisinin, derived from Artemisia plant extract, is redefining experimental workflows in antimalarial and cell signaling research. Explore streamlined protocols, troubleshooting strategies, and actionable insights that set this compound apart for mTOR pathway studies and translational applications.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor Workflows

  2026-04-17

  Sitagliptin phosphate monohydrate from APExBIO empowers metabolic and cellular researchers with precise, reproducible modulation of incretin pathways. This guide translates cutting-edge evidence and protocol optimization into actionable workflows for type II diabetes treatment research and beyond.

• AZD0156 (SKU B7822): Enhancing ATM Kinase Inhibition in Canc

  2026-04-16

  This article addresses common laboratory challenges in cell viability and cytotoxicity assays using AZD0156 (SKU B7822), a selective ATM kinase inhibitor. Leveraging real-world scenarios, the discussion synthesizes protocol best practices, product reliability, and data interpretation—empowering researchers to drive reproducibility and sensitivity in DNA damage response studies with confidence.

• IgSF6 Deficiency Enhances Antibacterial Defense via ER Stres

  2026-04-15

  This study uncovers that loss of the ER-localized immunoglobulin IgSF6 in intestinal macrophages promotes antibacterial activity by increasing ER stress and inflammatory responses. The findings highlight a novel regulatory mechanism with implications for gut immune homeostasis and disease susceptibility.

444 records 20/30 page Previous Next First page 上5页 1617181920 下5页 Last page